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It’s a Small World after All
In a trend that matches the proliferation of stem cell-related publications, the ISSCR continues
to attract top-tier members and scientific reports to its annual meetings. Highlights of this year’s
conference, held in June in Cairns, Australia, are adeptly reported by Orkin and Pera in this
issue’s Society section, and underscore just how widespread stem cell research has become.
The Profile article included in this issue features another kind of international collaboration, in
which scientists of many nationalities are being brought together under the Biopolis umbrella
in Singapore. The Biopolis model of bringing researchers from around the world together and
providing abundant supportive resources may become a blueprint for replication across the
globe.
Image courtesy of A*STAR, the Agency for Science, Technology and Research.
Pluripotent Cells: Not Just from a Blastocyst Anymore
This issue features two interesting yet distinct steps towardmaking pluripotent cells from sources other than fertilized eggs.
The Daley group demonstrate that their method for identifying murine parthenogenetic-derived lines also applies to human
cells, and reveal that the SCNT-hES-1 cell line described in the retracted paper by Huang and colleagues was, in fact, the
first reported instance of a human ES cell line generated by parthenogenesis. From another angle, Ramalho-Santos and
colleagues develop on the recent iPS cell papers published here (Maherali et al, inaugural issue) and in Nature by showing
that primitive, likely pluripotent cells can be selected frommurine fibroblasts expressing the ‘‘four factors’’ based on colony
morphology alone, without the need for drug-based selection. Many challenges still remain, but this advance removes one
of the hurdles that stood in the way of widespread use of the iPS cell protocol in research and eventual application in a
clinical setting.
Bivalent Domains in hES Cells and Beyond
Despite the restrictions imposed on studies using human ES cells, the number of laboratories
working with them is growing at a rapid rate. Recognizing that ES cell techniques vary widely be-
tween researchers, leading scientists in the field have collaborated to publish a manual of stan-
dardized practices. As reviewed in this issue by Auerbach and Josephson, book editors Cowan,
Eggan, and Sullivan have also established an online community with the intention of keeping their
collection of methods current in this rapidly evolving area. Also in this issue, two research papers
from the Thomson and Wei labs demonstrate strikingly reproducible genomic-scale hESC
analyses. As previewed by Sharov and Ko, these two independent, genome-wide profiling efforts
reveal highly overlapping sets of genes that are marked with ‘‘bivalent domains,’’ in that their promoters carry both activat-
ing and repressive histone trimethylations. The discovery that these comodifications are present on a conserved set of
genes in human as well asmouse pluripotent cells underscores their potential importance. However, the studies also reveal
that this epigenetic signature is not exclusive to ES cells, raising questions about its proposed functional role.
A New Resource for Experts and Novices Alike
This issue features a newReview article format that provides a constructive survey of the strengths and limitations of assays
used in stem cell biology. In a field that benefits from interdisciplinary advances, Protocol Reviews will provide a forum for
researchers to learn about laboratory approaches that they do not currently use, to help with interpretation of papers and
with adapting methods across scientific borders. To launch this section, Purton and Scadden contribute an overview of the
use of limiting dilution assays to studymurine hematopoietic stem cells. The caveats and considerations raised in this paper
are relevant across multiple platforms, especially the burgeoning field of cancer stem cells, or in any situation in which rare
cells are detected based on their function.
Stem Cells on the Move
What does the Drosophila ovariole have in common with human pancreatic cancer? It’s all about
movement, it seems. In this issue, Nystul and Spradling reveal that precisely two follicle stem cells
(FSC) exist in acellular niches on opposite sides of the fly ovariole. They show that if one of these cells
is lost, it is replaced by migration of FSC progeny from the opposing niche, rather than by neighbor-
ing cells. In another stem cell migration story, Hermann et al. demonstrate that human pancreatic
cancer, which can be transplanted into animal models by a population of CD133+ cells, also contains
a metastasis-inducing cell subpopulation that coexpresses the chemokine receptor CXCR4. Iden-
tifying and characterizing individual cell subsets that are responsible for tumor generation or tumor
migration are important steps forward in designing new therapeutic approaches for this dangerous
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